« Previous Next » Biology of Blood and Marrow Transplantation
Volume 16, Issue 2 , Pages 223-230 , February 2010

Hematopoietic Stem Cell Transplantation for Refractory or Recurrent Non-Hodgkin Lymphoma in Children and Adolescents

Thomas G. Gross
- Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio
- Correspondence and reprint requests: Thomas G. Gross, MD, PhD, Department of Pediatrics, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205.
Gregory A. Hale
- Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, Tennessee
Wensheng He
- Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
Bruce M. Camitta
- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
Jean E. Sanders
- Department of Pediatrics, Fred Hutchinson Cancer Research Center, Seattle, Washington
Mitchell S. Cairo
- Department of Pediatrics, New York Presbyterian Hospital, New York, New York
Robert J. Hayashi
- Department of Pediatrics, St. Louis Children's Hospital, St. Louis, Missouri
Amanda M. Termuhlen
- Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio
Mei-Jie Zhang
- Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
Stella M. Davies
- Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Mary Eapen
- Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin
- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin

Received 27 August 2009 ,Accepted 24 September 2009.

The probability of recurrent or progressive disease after allogeneic and autologous transplantation for Non-Hodgkin lymphoma: Diffuse Large Cell (1A), Lymphoblastic (1B), Burkitt (1C) and Anaplastic (

The probability of recurrent or progressive disease after allogeneic and autologous transplantation for Non-Hodgkin lymphoma: Diffuse Large Cell (1A), Lymphoblastic (1B), Burkitt (1C) and Anaplastic (1D).
- Full-Size Image
- Download to PowerPoint
The probability of event-free survival after allogeneic and autologous transplantation for Non-Hodgkin lymphoma: Diffuse Large Cell (1A), Lymphoblastic (1B), Burkitt (1C) and Anaplastic (1D).

The probability of event-free survival after allogeneic and autologous transplantation for Non-Hodgkin lymphoma: Diffuse Large Cell (1A), Lymphoblastic (1B), Burkitt (1C) and Anaplastic (1D).
- Full-Size Image
- Download to PowerPoint